Literature DB >> 1969297

Multiple endocrine neoplasia type 2.

B Ponder1.   

Abstract

Entities:  

Mesh:

Year:  1990        PMID: 1969297      PMCID: PMC1662269          DOI: 10.1136/bmj.300.6723.484

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

1.  Linked markers flanking the gene for multiple endocrine neoplasia type 2A.

Authors:  Y Nakamura; C G Mathew; H Sobol; D F Easton; H Telenius; T Bragg; K Chin; J Clark; C Jones; G M Lenoir
Journal:  Genomics       Date:  1989-08       Impact factor: 5.736

2.  Screening for multiple endocrine neoplasia type 2a with DNA-polymorphism analysis.

Authors:  H Sobol; S A Narod; Y Nakamura; A Boneu; C Calmettes; D Chadenas; G Charpentier; J F Chatal; N Delepine; M J Delisle
Journal:  N Engl J Med       Date:  1989-10-12       Impact factor: 91.245

3.  A method for generating hybrids containing nonselected fragments of human chromosomes.

Authors:  F Benham; K Hart; J Crolla; M Bobrow; M Francavilla; P N Goodfellow
Journal:  Genomics       Date:  1989-05       Impact factor: 5.736

Review 4.  Multiple endocrine neoplasia.

Authors:  R V Thakker; B A Ponder
Journal:  Baillieres Clin Endocrinol Metab       Date:  1988-11

5.  Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage.

Authors:  N E Simpson; K K Kidd; P J Goodfellow; H McDermid; S Myers; J R Kidd; C E Jackson; A M Duncan; L A Farrer; K Brasch
Journal:  Nature       Date:  1987 Aug 6-12       Impact factor: 49.962

6.  A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10.

Authors:  C G Mathew; K S Chin; D F Easton; K Thorpe; C Carter; G I Liou; S L Fong; C D Bridges; H Haak; A C Kruseman
Journal:  Nature       Date:  1987 Aug 6-12       Impact factor: 49.962

  6 in total
  1 in total

Review 1.  Thyroid cancer: a review of treatment and follow-up.

Authors:  L Vini; C Harmer; V R McCready
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.